Tag: COMMAND trial

first command implant

First US Stentrode implant heralds new field in neurointerventional surgery

Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...

Synchron enrols first patient in US COMMAND study of endovascular brain-computer...

Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...

Brain-computer interface technology opens up “whole new world” of therapies

 “We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
synchron stentrode safety

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
synchron stentrode safety

Synchron given green light to begin US study of endovascular brain-computer...

The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...